Last reviewed · How we verify

NCT04814238: MIRAGE

Minimally Invasive Aortic Root and Aorta surGery rEgistry

Status unknown Last updated 24 March 2021
What this trial tests

trial testing Aortic Root Surgery in Aortic Aneurysm, Thoracic in 2,000 participants. Status unknown.

Timeline
22 March 2021
Primary endpoint
1 January 2022
1 January 2023

Quick facts

Lead sponsorNicolaus Copernicus University
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment2,000
Start date22 March 2021
Primary completion1 January 2022
Estimated completion1 January 2023
Sites1 location across Poland

Drugs / interventions tested

Conditions studied

Sponsor

Nicolaus Copernicus University

Who can join

18 and older, any sex, with Aortic Aneurysm, Thoracic. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Minimally invasive aortic valve (AV) surgery has become widely accepted alternative to standard sternotomy. Despite possible reduction in morbidity, this approach is not routinely performed for aortic surgery. Evidence exists, however, on safety of this approach together with promising results regarding its long-term durability. The MIRAGE Registry is aimed to collect and analyse the data from multiple aortic excellence centres and to analyse them in numerous clinical scenarios.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Aortic Aneurysm, Thoracic

Currently open trials in the same condition.

Other Nicolaus Copernicus University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04814238.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing